Gamelin Erick 4
4 · Acrivon Therapeutics, Inc. · Filed Aug 18, 2025
Insider Transaction Report
Form 4
Gamelin Erick
Chief Development Officer
Transactions
- Tax Payment
Common Stock
2025-08-14$1.39/sh−403$560→ 15,686 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.